1.
An Experimental Study on Effect of Chemotherapeutic Agents Combined with Nimotuzumab on Human Colon Cell Line LoVo
尼妥珠单抗联合化疗药物对人结肠癌细胞株LoVo的实验研究
2.
Primary study of nimotuzumab combined with radiotherapy and concomitant temozolomide chemotherapy treatment for high-grade glioma
尼妥珠单抗联合放疗加同期替莫唑胺治疗高分级胶质瘤的初步研究
3.
Experimental Study of Therapeutic Effect of Trastuzumab in Combination with 5-Fu and/or Cisplatin on Gastric Cancer Cells;
曲妥珠单抗联合5-氟尿嘧啶和/或顺铂治疗胃癌的实验研究
4.
Trastuzumab in combination with gemcitabine as salvage therapy in metastatic breast cancer with Her2-positive
曲妥珠单抗联合吉西他滨治疗HER2阳性的转移性乳腺癌
5.
The basic principles and strategies of adjuvant therapy with trastuzumab in breast cancer
曲妥珠单抗用于乳腺癌辅助治疗的基本原则与策略
6.
A meta-analysis of neoadjuvant chemotherapy combined with trastuzumab for HER2-positive breast cancers
联合曲妥珠单抗的新辅助化疗方案用于HER2阳性乳腺癌的Meta分析
7.
Bacterial Endotoxin Test of Cetuximab Injection
西妥昔单抗注射液细菌内毒素检查法
8.
A experimental study on inhibiting effect of cetuximab on angiogenesis
西妥昔单抗抑制血管生成的实验研究
9.
The nursing experience of rituximab in combined with chemotherapy in elderly patient with non-hodgkin s lymphoma;
利妥昔单抗治疗老年非霍奇金淋巴瘤护理体会
10.
Cetuximab plus chemotherapy in the treatment of patients with head and neck squamous cell carcinomas (HNSCC)
西妥昔单抗联合化疗治疗头颈部鳞癌初步研究
11.
Treatment of B-cell Lymphoma with the Regimen of Rituximab Combined Chemotherapy
利妥昔单抗联合化疗方案治疗B细胞淋巴瘤
12.
Protection of ward of liver cancer patients after undergoing ~(131)I rituximab intervention therapy
~(131)碘美妥昔单抗介入治疗肝癌术后病室的防护
13.
Cetuximab for the treatment of metastatic colorectal cancer:a meta-analysis
西妥昔单抗治疗转移性结直肠癌的荟萃分析
14.
Cetuximab plus chemotherapy agents in the treatment of metastic colorectal cancer and literature review
西妥昔单抗联合化疗治疗转移性结直肠癌
15.
Construction and Screening of Human Single-chain Antibody Library for Candida albicans
抗白念珠菌人源性单链抗体库的构建及筛选
16.
Study on the Sepcificity of the New Monoclonal Antibody03.2C1-C2 Gainst Candida Albicans Germ-tube and Its Epitope Characterization of the Target Antigen;
抗白念珠菌芽管单抗MAb03.2C1-C2特异性及靶抗原性质的初步研究
17.
The reintroduction of Natalizumab and its risk management plan;
那他珠单抗重返市场给药品风险管理的启示
18.
Preparation and identification of monoclonal antibody against enolase of candida albicans
白念珠菌烯醇化酶单克隆抗体的制备及鉴定